| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.18B | 1.15B | 1.14B | 900.50M | 947.00M |
| Gross Profit | 428.00M | 413.00M | 406.50M | 300.10M | 304.90M |
| EBITDA | 253.90M | 232.40M | 222.70M | 169.70M | 179.60M |
| Net Income | 136.60M | 124.90M | 112.50M | 77.50M | 106.00M |
Balance Sheet | |||||
| Total Assets | 2.22B | 2.25B | 2.33B | 2.53B | 2.27B |
| Cash, Cash Equivalents and Short-Term Investments | 242.10M | 191.50M | 102.30M | 54.30M | 4.20M |
| Total Debt | 339.20M | 335.10M | 337.90M | 339.30M | 336.90M |
| Total Liabilities | 814.30M | 809.70M | 1.01B | 1.03B | 1.09B |
| Stockholders Equity | 1.41B | 1.44B | 1.33B | 1.51B | 1.18B |
Cash Flow | |||||
| Free Cash Flow | 145.40M | 116.70M | 88.90M | 66.90M | 62.00M |
| Operating Cash Flow | 186.00M | 158.10M | 121.70M | 90.10M | 85.60M |
| Investing Cash Flow | -96.00M | -41.40M | -62.10M | -23.20M | 13.80M |
| Financing Cash Flow | -39.40M | -27.50M | -20.70M | -13.70M | -276.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.93B | 18.76 | 14.99% | 2.06% | 9.52% | 17.22% | |
74 Outperform | £1.73B | 7.84 | 15.61% | 1.62% | 2.31% | 9.04% | |
69 Neutral | £1.58B | 161.43 | 0.73% | 0.79% | 25.76% | -73.03% | |
65 Neutral | £2.45B | 25.38 | 6.17% | 5.27% | 15.55% | 42.40% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | £461.17M | 9.64 | 14.17% | 7.01% | 5.67% | 22.05% |